Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Bilz

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Therapeutische Umschau. Revue Therapeutique|February 21, 2018
Stefan Bilz
Praxis|May 8, 2025
[Drug-induced adrenal insufficiency]Sofia Flores Borsari, Stefan Bilz
Praxis|January 22, 2026
[Diagnostic steps and management of a rare cause of hypercalcemia]Natalie Grob, Markus Koster, Stefan Bilz
Metabolism: Clinical and Experimental|May 31, 2002
Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in manUlrich Keller, Igor Turkalj, Roland Laager, et al.
Frontiers in Endocrinology|June 15, 2026
Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets - a SwissDiab studyChristina Liu, Frida Renström, Giacomo Gastaldi, et al.
BMJ Open Diabetes Research & Care|August 25, 2022
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)Julia K Mader, Stefan Gölz, Stefan Bilz, et al.
Praxis|November 12, 2024
[A rare side effect of antithyroid drug therapy]Armgard Büchel-Boekstegers, Markus Koster, Sven Lieberherr, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 2, 2024
Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort StudyMaximilian Boesch, Florent Baty, Stefan Bilz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 2, 2024
Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T StudyStefan Gölz, Julia K Mader, Stefan Bilz, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized AcromegalyMarino Quarella, Daniel Walser, Michael Brändle, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Therapeutische Umschau. Revue Therapeutique|February 21, 2018
Stefan Bilz
Praxis|May 8, 2025
[Drug-induced adrenal insufficiency]Sofia Flores Borsari, Stefan Bilz
Praxis|January 22, 2026
[Diagnostic steps and management of a rare cause of hypercalcemia]Natalie Grob, Markus Koster, Stefan Bilz
Metabolism: Clinical and Experimental|May 31, 2002
Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in manUlrich Keller, Igor Turkalj, Roland Laager, et al.
Frontiers in Endocrinology|June 15, 2026
Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets - a SwissDiab studyChristina Liu, Frida Renström, Giacomo Gastaldi, et al.
BMJ Open Diabetes Research & Care|August 25, 2022
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)Julia K Mader, Stefan Gölz, Stefan Bilz, et al.
Praxis|November 12, 2024
[A rare side effect of antithyroid drug therapy]Armgard Büchel-Boekstegers, Markus Koster, Sven Lieberherr, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 2, 2024
Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort StudyMaximilian Boesch, Florent Baty, Stefan Bilz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 2, 2024
Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T StudyStefan Gölz, Julia K Mader, Stefan Bilz, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized AcromegalyMarino Quarella, Daniel Walser, Michael Brändle, et al.
Pageof 6